0001209191-22-042609.txt : 20220719
0001209191-22-042609.hdr.sgml : 20220719
20220719172109
ACCESSION NUMBER: 0001209191-22-042609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220715
FILED AS OF DATE: 20220719
DATE AS OF CHANGE: 20220719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Dongfang
CENTRAL INDEX KEY: 0001937915
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 221092267
MAIL ADDRESS:
STREET 1: C/O NUVATION BIO INC.
STREET 2: 1500 BROADWAY, SUITE 401
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER NAME:
FORMER CONFORMED NAME: Liu Donfang
DATE OF NAME CHANGE: 20220713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvation Bio Inc.
CENTRAL INDEX KEY: 0001811063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850862255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Panacea Acquisition Corp
DATE OF NAME CHANGE: 20200430
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-15
0
0001811063
Nuvation Bio Inc.
NUVB
0001937915
Liu Dongfang
C/O NUVATION BIO INC.
1500 BROADWAY, SUITE 401
NEW YORK
NY
10036
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
3.61
2022-07-15
4
A
0
490000
0.00
A
2032-07-14
Common Stock
490000
490000
D
Stock Option (Right to Buy)
3.61
2022-07-15
4
A
0
292500
0.00
A
2032-07-14
Common Stock
292500
292500
D
Option vests as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.
Dongfang Liu, by /s/ Ron A. Metzger, Attorney-in-Fact
2022-07-19